Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals
Clique no link Therapeutic monoclonal antibodies scFv patents as a marker of a new class of potential biopharmaceuticals.pdf para ver o arquivo.